Search Results - Eleni Frangou

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome by Ricardo Romero-Guevara, Orthodoxia Nicolaou, Benedetta Petracca, Sadr Shaheed, Christopher Sutton, Eleni Frangou, Eleni Frangou, Marina Afami, Kyriacos Kyriacou, Adonis Ioannides, Christodoulos Xinaris, Christodoulos Xinaris

    Get full text
    Article


  2. 2

    Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy by Dimitrios Nikolakis, Panagiotis Garantziotis, George Sentis, Antonis Fanouriakis, George Bertsias, Eleni Frangou, Dionysis Nikolopoulos, Aggelos Banos, Dimitrios T Boumpas

    Published in BMC Genomics (2023-04-01)
    Get full text
    Article


  3. 3

    Determining the Impact of Histology on the Incidence, Pattern, and Timing of Recurrences in Patients with Renal Cell Carcinoma: A Pooled Analysis from the SORCE and ASSURE Trials by Bhavna Oza, Eleni Frangou, Tim Eisen, Grant D. Stewart, Axel Bex, David Harrison, Mahesh K.B. Parmar, Ruth Langley, Duncan Gilbert, Angela Meade

    Published in European Urology Open Science (2025-09-01)
    Get full text
    Article


  4. 4

    EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis— the European Renal Association (ERA) — Immunonephrology Working Group (ERA-IWG) perspe... by Eleni Frangou, Annette Bruchfeld, Gema M. Fernandez-Juarez, Jürgen Floege, Dimitrios Goumenos, Sarah M. Moran, Stefanie Steiger, Kate I. Stevens, Kultigin Turkmen, Andreas Kronbichler

    Published in Počki (2023-12-01)
    Get full text
    Article


  5. 5

    Quo Vadis Standardization of Anti-Nephrin Antibody Detection? by Safak Mirioglu, Annette Bruchfeld, Fernando Caravaca-Fontan, Jürgen Floege, Eleni Frangou, Sarah M. Moran, Kate I. Stevens, Y.K. Onno Teng, Stefanie Steiger, Andreas Kronbichler

    Published in Glomerular Diseases (2025-04-01)
    Get full text
    Article


  6. 6

    Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double‐blind placebo‐controlled crossover trial... by Arjune Sen, Sofia Toniolo, Xin You Tai, Mary Akinola, Mkael Symmonds, Sergio Mura, Joanne Galloway, Angela Hallam, Jane Y. C. Chan, Ivan Koychev, Chris Butler, John Geddes, Gabriel Davis Jones, Younes Tabi, Raquel Maio, Eleni Frangou, Sharon Love, Sian Thompson, Rohan Van Der Putt, Sanjay G. Manohar, Rupert McShane, Masud Husain

    Published in Epilepsia Open (2024-12-01)
    Get full text
    Article


  7. 7

    Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study) by Grazia Daniela Femminella, Eleni Frangou, Sharon B. Love, Gail Busza, Clive Holmes, Craig Ritchie, Robert Lawrence, Brady McFarlane, George Tadros, Basil H. Ridha, Carol Bannister, Zuzana Walker, Hilary Archer, Elizabeth Coulthard, Ben R. Underwood, Aparna Prasanna, Paul Koranteng, Salman Karim, Kehinde Junaid, Bernadette McGuinness, Ramin Nilforooshan, Ajay Macharouthu, Andrew Donaldson, Simon Thacker, Gregor Russell, Naghma Malik, Vandana Mate, Lucy Knight, Sajeev Kshemendran, John Harrison, David J. Brooks, Anthony Peter Passmore, Clive Ballard, Paul Edison

    Published in Trials (2019-04-01)
    Get full text
    Article


Search Tools: